LONDON, ENGLAND--(Marketwired - Oct. 14, 2015) - Cancer survival rates have increased dramatically in recent decades, thanks in no small part to serious breakthroughs in immunotherapy, which, if successful, could turn cancer into a chronic, manageable disease. The new issue of The New Economy pours over the latest developments in immuno-oncology and asks whether it could be the hope the world has waited for.

"The disease still affects millions of people around the world each year, regardless of age, ethnicity and economic standing", says The New Economy report, which goes on to analyse the shortfalls of existing treatments. "But now there is an alternative method: one that combats cancer in a completely different way from its predecessors and potentially heralds a revolutionary era in treatment."

Immuno-oncology, according to The New Economy, uses the body's natural defense mechanisms to fight cancer without causing harm to otherwise healthy cells. However, the high costs tied to it mean the latest developments are restricted largely to the most formidable of pharmaceuticals players, though there are a few smaller biotechnology firms making waves in immuno-oncology research.

The challenge for now is to figure out how these treatments can be standardised, streamlined and made affordable for general clinical deployment. "While perhaps not yet a cancer cure, we may be able to turn cancer from being a terminal disease into just a chronic disease", says Stephen Dunn, Senior Managing Director of Research for LifeTech Capital. "The best is yet to come."

To read the report in full and many more on the subjects of technology, energy, business and strategy, pick up the latest issue of The New Economy, available in print, on mobile devices and online now.

World News Media is a leading publisher of quality financial and business magazines, enjoying a global distribution network that includes subscriber lists of the most prominent and senior decision-makers around the world, as well as comprehensive airport, hotel and conference site distribution.

Contact Information:

For further media information contact:
The New Economy
Matthew Timms
Editorial Department
+44 (0)20 7553 4177